Key Highlights

● Needham reportedly initiated coverage with a Buy rating.

● The price target was set at $6 a share.

● Clover Health focuses on Medicare Advantage plans.

● The company also develops the Clover Assistant physician software.

Clover Health Investments (NASDAQ:CLOV) rose after Needham reportedly started covering the stock with a Buy rating and a price target of $6, according to an aggregated market news report. Clover's stock moved higher during the session following the reported initiation.

The report was the only source found for the analyst action, so the details should be read with some caution.

Why a New Rating Can Move a Stock

When a brokerage begins covering a company, it typically publishes a detailed report laying out its view of the business alongside a rating and price target, which can draw fresh attention to a smaller company followed by relatively few analysts.

Clover Health is a health insurance company focused on Medicare Advantage, the private alternative to traditional Medicare for Americans aged 65 and older, offered in a number of US states.

Technology Alongside Insurance

The company also develops technology including its Clover Assistant software, designed to give doctors data and insights at the point of care to help manage chronic conditions and catch health problems earlier.

Medicare Advantage insurers have faced pressure in recent years from rising medical costs and changes to government payment rates, which has made investors pay close attention to profitability across the industry.